Press / Medias

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

A new patent licencing deal between Cornell and LNC Therapeutics will help the French biotech become the ‘must have’ partner for research and product development relating to the Christensenella strain, says the company’s CEO.

Clic here to read the full article

 

 

In the same category

Press / Medias

YSOPIA Bioscience : Restaurer le microbiome pour soigner !

Apr 14, 2022

more +
Press / Medias

Seventure Partners : Une croissance continue dans le secteur du microbiome en 2021 qui va se...

Mar 15, 2022

more +
Press / Medias

Inria partage son expertise avec la biotech bordelaise Ysopia

Feb 2, 2022

more +

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions